Marco Mazzotta

2.0k total citations
40 papers, 846 citations indexed

About

Marco Mazzotta is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Marco Mazzotta has authored 40 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Marco Mazzotta's work include Cancer Immunotherapy and Biomarkers (7 papers), HER2/EGFR in Cancer Research (6 papers) and Advanced Breast Cancer Therapies (5 papers). Marco Mazzotta is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), HER2/EGFR in Cancer Research (6 papers) and Advanced Breast Cancer Therapies (5 papers). Marco Mazzotta collaborates with scholars based in Italy, Malaysia and United States. Marco Mazzotta's co-authors include Lorenzo Lo Muzio, Corrado Rubini, Francesco Carinci, Furio Pezzetti, Luca Scapoli, Annalisa Palmieri, Eriseld Krasniqi, Paolo Marchetti, Patrizia Vici and Laura Pizzuti and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Marco Mazzotta

37 papers receiving 835 citations

Peers

Marco Mazzotta

ONCOL

PRM

IMMUN

Tami Yap Australia

Asawari Patil India

Anupam Sarma India

Liting Qian China

Hélio Humberto Angotti Carrara Brazil

Francesca Pezzuto Italy

Victor Lopes United Kingdom

Joseph Tung‐Chieh Chang Taiwan

Shang‐Yin Wu Taiwan

Amir Khan Pakistan

Tami Yap Australia

Marco Mazzotta

263 ×0.7

123 ×0.4

ONCOL

142 ×0.5

127 ×0.7

PRM

31 ×0.4

IMMUN

Citations per year, relative to Marco Mazzotta Marco Mazzotta (= 1×) peers Tami Yap

Countries citing papers authored by Marco Mazzotta

Since Specialization

Citations

This map shows the geographic impact of Marco Mazzotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Mazzotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Mazzotta more than expected).

Fields of papers citing papers by Marco Mazzotta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Mazzotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Mazzotta. The network helps show where Marco Mazzotta may publish in the future.

Co-authorship network of co-authors of Marco Mazzotta

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Mazzotta. A scholar is included among the top collaborators of Marco Mazzotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Mazzotta. Marco Mazzotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nelli, Fabrizio, Agnese Fabbri, Diana Giannarelli, et al.. (2022). Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: Results from the Vax-On-Profile study. International Immunopharmacology. 108. 108774–108774. 5 indexed citations

Signorelli, Carlo, Pietro Maria Amodio, Mario Giovanni Chilelli, et al.. (2022). Real-Life Experience of the Prognostic Significance of the Primary Tumor Location on the Timing of Colorectal Liver Metastases: A Retrospective Analysis. Cureus. 14(10). e30607–e30607.

Scalera, Stefano, Marco Mazzotta, Eriseld Krasniqi, et al.. (2022). KEAP1-Mutant NSCLC: The Catastrophic Failure of a Cell-Protecting Hub. Journal of Thoracic Oncology. 17(6). 751–757. 43 indexed citations

Chilelli, Mario Giovanni, Carlo Signorelli, Fabrizio Nelli, et al.. (2022). Immune-related Thyroid Dysfunction (irTD) in Non-small Cell Lung Cancer (NSCLC) Correlates With Response and Survival. Cancer Diagnosis & Prognosis. 2(1). 55–63. 3 indexed citations

Ruggeri, Enzo Maria, Fabrizio Nelli, Diana Giannarelli, et al.. (2022). Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients. Scientific Reports. 12(1). 21908–21908. 5 indexed citations

Grassadonia, Antonino, Vincenzo Graziano, Laura Iezzi, et al.. (2021). Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting. Cells. 10(7). 1685–1685. 28 indexed citations

Perrone, Fabiana, Lorenzo Belluomini, Marco Mazzotta, et al.. (2021). Exploring the role of respiratory microbiome in lung cancer: A systematic review. Critical Reviews in Oncology/Hematology. 164. 103404–103404. 24 indexed citations

Ruggeri, Enzo Maria, Fabrizio Nelli, Agnese Fabbri, et al.. (2021). Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study. ESMO Open. 7(1). 100350–100350. 6 indexed citations

Vici, Patrizia, Eriseld Krasniqi, Laura Pizzuti, et al.. (2021). Burnout of health care providers during the COVID-19 pandemic: Focus on Medical Oncologists. International Journal of Medical Sciences. 18(10). 2235–2238. 3 indexed citations

10.

Pizzuti, Laura, Eriseld Krasniqi, Chiara Mandoj, et al.. (2020). Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS Trial. Cancers. 12(4). 849–849. 2 indexed citations

11.

Krasniqi, Eriseld, Giacomo Barchiesi, Marco Mazzotta, et al.. (2020). Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestane. Medicine. 99(31). e21211–e21211. 3 indexed citations

12.

Marinelli, Daniele, Raffaele Giusti, Marco Mazzotta, et al.. (2020). Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives. Critical Reviews in Oncology/Hematology. 157. 103176–103176. 11 indexed citations

13.

Giusti, Raffaele, Emanuela Scarpi, Katia Cannita, et al.. (2019). Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors. Supportive Care in Cancer. 28(3). 1051–1058.

14.

Botticelli, Andrea, Massimiliano Salati, Francesca Romana Di Pietro, et al.. (2019). A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab. Journal of Translational Medicine. 17(1). 99–99. 43 indexed citations

15.

Giusti, Raffaele, Marco Mazzotta, Marco Filetti, et al.. (2019). Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice. Supportive Care in Cancer. 27(9). 3531–3535. 3 indexed citations

16.

Krasniqi, Eriseld, Giacomo Barchiesi, Laura Pizzuti, et al.. (2019). Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives. Journal of Hematology & Oncology. 12(1). 111–111. 96 indexed citations

17.

Pizzuti, Laura, Eriseld Krasniqi, Giacomo Barchiesi, et al.. (2019). Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios. Journal of Cancer. 10(24). 5903–5914. 12 indexed citations

18.

Onesti, Concetta Elisa, Daniela Iacono, Marco Mazzotta, et al.. (2018). Four lines of anaplastic lymphoma kinase inhibitors and brain radiotherapy in a long-surviving non-small-cell lung cancer anaplastic lymphoma kinase-positive patient with leptomeningeal carcinomatosis. Anti-Cancer Drugs. 30(2). 201–204. 3 indexed citations

19.

Onesti, Concetta Elisa, Daniela Iacono, Salvatore Di Lauro, et al.. (2016). Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literature. Translational Lung Cancer Research. 5(6). 712–719. 12 indexed citations

20.

Scapoli, Luca, Annalisa Palmieri, Lorenzo Lo Muzio, et al.. (2010). MicroRNA Expression Profiling of Oral Carcinoma Identifies New Markers of Tumor Progression. International Journal of Immunopathology and Pharmacology. 23(4). 1229–1234. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact